Weave Communications 
What happened
Francisco Partners, a private equity firm with a track record of software and technology acquisitions, agreed to acquire 100% of Weave Communications at $7.40 per share. The consideration is entirely cash, removing equity risk for existing holders. Weave reported quarterly earnings on August 6, 2026, posting EPS of $0.04 in line with estimates and revenue of $67.54 million, narrowly missing the $67.88 million consensus estimate.
WEAV opened at $7.29 on August 18 and touched $7.30 with approximately 16.1 million shares changing hands. The stock last traded near $6.70 before the announcement. At the offer price, Francisco Partners is paying a modest premium to the pre - news close, reflecting Weave's market position in customer communications software for small and medium - sized healthcare and service businesses. The company employs roughly 854 people and operates primarily in the United States and Canada.
The definitive merger agreement contains standard deal protections including a go - shop provision (if applicable) and representations/warranties typical for take - private transactions of this size. No specific closing timeline was disclosed in the initial disclosure.
Why it matters
The acquisition removes a publicly traded small - cap software name from the market at a moment when the stock was trading below its 52 - week high. For current stockholders, the $7.40 per share offer provides a known exit price, though the premium to the pre - announcement close is modest given Weave's recent business development activity including enterprise AI receptionist features launched in Q2 2026.
For acquirers like Francisco Partners, Weave's platform serving SMB front - office workflows in healthcare represents a consolidating asset in a niche vertical. Private equity buyers have been active in acquiring profitable or near - profitable SaaS businesses trading at discounted multiples following the 2022 - 2024 valuation correction. The $650 million price tag values WEAV at approximately 2.4x trailing quarterly revenue run rate, a reasonable multiple for a cash - generative communications platform.
The deal also illustrates continued private equity appetite for healthcare - adjacent technology platforms. Weave's authorized integration ecosystem with electronic health record vendors such as Elation Health gives Francisco Partners a recurring - revenue moat to leverage post - privatization.
What to watch next
Stockholders should monitor for the filing of an SEC Schedule 14A proxy statement outlining the deal terms, board recommendations, and shareholder meeting date. The proxy vote is the primary near - term catalyst before closing. Any regulatory review from the FTC or DOJ could introduce timeline uncertainty, particularly given Weave's healthcare data touchpoints. If the deal is expected to close within the next 60 to 90 days, a Form 8 - K disclosure confirming proxy mailing would be expected. Watch for unusual options activity in WEAV as dealers hedge around the $7.40 strike ahead of the vote.